Serum cystatin C, enzymuria, tubular proteinuria and early renal insult in type 2 diabetes

British Journal of Biomedical Science

Volumn 64, Issue 3, 2007, Pages 121-123

  Kalansooriya, A ^a   Holbrook, I ^b   Jennings, P ^b   Whiting, Paul H ^a  

^a DE MONTFORT UNIVERSITY   (United Kingdom)

^b YORK HOSPITAL   (United Kingdom)

Author keywords

Cystatin C; Diabetes, type 2; Tubular proteinuria

Indexed keywords

ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; CREATININE; CYSTATIN C; N ACETYL BETA GLUCOSAMINIDASE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD CHEMISTRY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; ENZYME BLOOD LEVEL; ENZYMURIA; FEMALE; HUMAN; KIDNEY TUBULE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; STATISTICAL SIGNIFICANCE; URINALYSIS;

EID: 34748884485     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2007.11732770     Document Type: Article

References (23)

1. Panchapakesan U, Xin-Ming C, Pollock CA. Drug insight: thiazolidinediones and diabetic nephropathy - relevance to renoprotection. Nat Clin Pract Nephrol 2005; 1: 33-43.
2. Mogenson CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. Diabetes 1993; 32: 64S-78S.
3. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent diabetic patients. N Engl J Med 1984; 311: 89-93.
4. Friedman EA, Friedman AL. Is there really good news about pandemic diabetic nephropathy? Nephrol Dial Transplant 2007; 22: 681-3.
5. Perrone RD, Madias NE, Levy AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933-53.
6. Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997; 43: 1016-22.
7. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function - a review. Clin Chem Lab Med 1999; 37: 389-95.
8. Price CP, Finney H. Developments in the assessment of glomerular filtration rate. Clin Chim Acta 2000; 297: 55-66.
9. Chantrel F, Agin A, Ofner M, Koehl C, Moulin B, Hannedouche T. Comparison of cystatin C versus creatinine for the detection of mild renal failure. Clin Nephrol 2000; 54: 374-81.
10. Harmoinen A, Kouri T, Wirta O et al. Evaluation of plasma cystatin C as a marker of glomerular filtration rate in patients with type 2 diabetes. Clin Nephrol 1999: 52: 363-70.
11. Whiting PH, Price RG. Importance of early detection of renal dysfunction: value of markers of early renal disease and damage. Clin Biochem 2001; 3: 3-8.
12. Jung K, Pergande M, Schimke E, Ratzman KP, Illus A. Urinary enzymes and low molecular mass protein as indicators of diabetic nephropathy. Clin Chem 1988; 34: 544-77.
13. Uslu S, Efe B, Alatas O et al. Serum cystatin C and urinary enzymes as screening markers of renal dysfunction in diabetic patients. J Nephrol 2005; 18: 559-67.
14. Price RG, Whiting PH. Urinary enzymes and nephrotoxicity in humans. In: Jung K, Matternheimer H, Burchards U eds. Urinary enzymes. Heidelberg: Springer-Verlag, 1992: 203-21.
15. Whiting PH, Ross IS, Borthwick L. Serum and urine N-acetyl-β-D- glucosaminidase in diabetics on diagnosis and subsequent treatment, and stable insulin-dependent diabetics. Clin Chim Acta 1979; 92: 459-63.
16. Hong C-Y, Hughes K, Chia K-S, Ng V, Ling S-L. Urinary α1-microglobulin as a marker of nephropathy in type 2 diabetic Asian subjects in Singapore. Diabetes Care 2003; 26: 338-42.
17. Aksun SA, Özmen, Özmen B et al. β2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy. Exp Clin Endocrinol Diabetes 2004; 112: 195-200.
18. Kyhse-Anderson J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindstrom V. Serum cystatin C determined by a rapid automated particle-enhanced turbidometric method is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994; 40: 1921-6.
19. Whiting PH, Ross IS, Borthwick L. N-acetyl-β-D-glucosaminidase levels and the onset of diabetic microangiopathy. Ann Clin Biochem 1983; 20: 15-9.
20. Jung M, Jung K. Low molecular weight proteins in serum as markers of glomerular filtration: cystatin C, α1-microglobulin and β2-microglobulin. Lab Med 1994; 18: 463-70.
21. Kurrle-Weittenhiller A, Engel W. Immunoturbidometric determination of urinary α1-microglobulin on Hitachi analysers. Clin Chem 1992; 38: 1090-1.
22. Christenssen AG, Grubb AG, Nilsson, J-Å, Norrgren K, Sterner G. Serum cystatin C is advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy. J Intern Med 2004; 256: 510-8.
23. Page MK, Bukki J, Luppa P, Neumeier D. Clinical value of cystatin C determination. Clin Chim Acta 2000; 297: 67-72.